OTHER GROUP COMPANIES
market

Board of Glaxosmithkline Pharmaceuticals appoints director

At meeting held on 16 May 2022

May 16, 2022 5:16 IST | capital market
The Board of Glaxosmithkline Pharmaceuticals at its meeting held on 16 May 2022 has approved the appointment of Manu Anand (DIN:00396716) an Additional Independent Director of the Company for a term of five years w.e.f. from 16 May 2022.Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity